Related Experiment Video
Updated: Mar 15, 2026

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
19.1K
Reversibility and β-sheet formation are decoupled in tau condensate aging
Charlotte M Fischer1, Irina A Edu1, Tomas Šneideris1
1Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom.
Summary
Tau protein condensates in Alzheimer's disease can become irreversibly aggregated, but this process is not directly linked to structural changes. Understanding these tau intermediates may reveal new therapeutic targets for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Biochemistry
- Structural Biology
Background:
- Neurofibrillary tangles (NFTs) composed of tau protein are hallmarks of Alzheimer's disease (AD) and correlate with cognitive decline.
- Biomolecular condensates of tau are early intermediates in aggregation, potentially facilitating pathological assembly in AD, ALS, and FTD.
- The transition from reversible tau condensates to irreversible, pathogenic aggregates remains mechanistically unclear.
Purpose of the Study:
- To investigate the phase behavior, structural transitions, and thermodynamic reversibility of tau during condensate aging.
- To elucidate the molecular basis of tau condensate evolution into irreversible aggregates.
- To determine if β-sheet enrichment and irreversible aggregation are coupled processes in tau pathology.
Main Methods:
- Mapping tau phase behavior during condensate aging.
- Analyzing structural transitions and thermodynamic reversibility of tau species.
- Characterizing tau intermediates using biophysical techniques (details not specified in abstract).
Main Results:
- Tau condensate aging involves distinct rates for β-sheet enrichment and irreversible aggregation, indicating they are mechanistically uncoupled.
- Identified β-sheet-rich tau condensates that are thermodynamically reversible.
- Discovered irreversible tau aggregates that lack β-sheet structure, challenging linear aggregation models.
- Revealed a diverse landscape of tau intermediates with varying structural and thermodynamic properties.
Conclusions:
- The pathological end state of tau aggregation is not a simple linear progression.
- Decoupling of structure (β-sheet content) and irreversibility in tau aggregates has significant implications for understanding neurodegenerative disease mechanisms.
- These findings offer potential new targets for therapeutic interventions aimed at preventing or reversing tau pathology.
Related Concept Videos
Amyloid Fibrils
12.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.6K
Amyloid Fibrils
6.9K
6.9K
Protein Folding
12.1K
Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
12.1K
Protein Folding
129.8K
Overview
129.8K
Bacterial Protein Maturation
666
Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
666

